SHARP
HOME
Japan Search
Press Releases
Press Release Serrch
August 3, 2007

Sharp Proves Effectiveness of Plasmacluster Ions*1 In Eliminating Serratia Bacteria in Collaboration with Dr. Melvin First, Professor Emeritus, Harvard School of Public Health

Effect Demonstrated in a 40-m3 Chamber

Sharp Corporation, using technology*2 developed by Dr. Melvin First, Professor Emeritus of the Harvard School of Public Health and a leading US authority on public health*3, has verified in a test chamber (volume of 40 m3) the effectiveness of Plasmacluster Ion Technology, a proprietary air purification system that eliminates harmful airborne substances by releasing positive and negative ions into the air, in eliminating a serratia bacteria*4 (airborne pathogenic bacterium).

Serratia bacteria is a well-known nosocomial pathogen that is present in hospitals and in environments with high humidity such as the sinks and bathrooms of ordinary homes. When people who are in a weakened physical state inhale airborne water droplets which contain this bacteria, it can lead to respiratory infections and diseases such as pneumonia.

Now, tests performed in a chamber having a volume of 40 m3 in a laboratory leveled Bio-Safety Level 3*5 to handle airborne microorganisms, virus experiments, and the like, confirm that when serratia bacteria were dispersed in the chamber and the change in concentration measured when Plasmacluster Ions were released into the space, 99% of the bacteria were eliminated in 38 minutes (Figure 1).

Sharp, in cooperation with academic institutions in all parts of the world, has thus far demonstrated that Plasmacluster Ions are effective in eliminating harmful airborne substances such as floating bacteria, fungi, viruses and allergens. Serratia becomes the 27th such species. Sharp is pushing ahead the technological developments further to contribute to create healthy environment.

In addition, based on the verification results obtained at this time, Sharp is actively working to expand its presence in the global air-conditioning market in North America, Europe, and ASEAN countries under the concept of "Fill every space with Plasmacluster Ions."



Effect of Plasmacluster Ions in eliminating airborne serratia bacteria

Figure 1: Effect of Plasmacluster Ions in eliminating airborne serratia bacteria
(Survival rate is calculated based on average data from three test runs. Natural attenuation is set at 100%.)

*1 Plasmacluster and Plasmacluster Ion are registered trademarks of Sharp Corporation.
*2 Extracts and analyzes an airborne pathogenic bacterium and virus in a 40-m3-volume chamber. It also helps to avoid bioterrorism.
*3 The science of studying the relationship between health and the natural, social and environmental factors to which humans are exposed. The results are applied to maintaining general health and improving disease prevention, and early detection and treatment.
*4 Disease-causing bacilli that float in the air and invade the human body through respiration.
*5 Bio-Safety Level 3: A classification for facilities capable of safely handling pathogens such as bacilli and viruses. Standards are set in each country based on the Laboratory Biosafety Manual established by the World Health Organization (WHO). Level 3 designates a facility capable of handling pathogens (tuberculosis [TB] bacterium, SARS virus, avian influenza virus, etc.) that cause serious or potentially lethal diseases in humans or animals, but for which effective methods of treatment and prevention have been established.


Overview of Tests
1. Description of experiment:
Disperse serratia bacteria into the air of a large Bio-Safety Level 3*5 chamber having a volume of 40 m3 (Figure 2) and measure the concentration of airborne microbes as Plasmacluster Ions are released into the space and also when no ions are present. Tests were repeated three times to confirm the reproducibility of the data, and the effectiveness of the Plasmacluster Ions in eliminating the bacteria determined.

2. Results:
We were able to verify that releasing Plasmacluster Ions into the space effectively eliminated 99% of airborne serratia bacteria in 38 minutes (Figure 3).

Figure 2: Airborne microorganism test chamber


Figure 3: Results of tests to eliminate airborne serratia bacteria (scale of graph represents bacteria count x 104).


· Serratia bacteria
Serratia bacteria are present in environments inhabited by people, and are especially numerous in places where the humidity is high. When persons in a weakened physical state, such as hospitalized patients, inhale the bacterium, it is known to cause nosocomial (hospital-acquired) infections leading to diseases such as infectious pneumonia and other respiratory illnesses. Because the bacterium may be present in a patient's throat and airways, the infection can be transmitted by airborne droplet nuclei (infection by the bacterium forming particles and dispersing in the air).

Figure 4: Electron microscope photograph of serratia bacteria


· Harvard School of Public Health
Harvard University is a private university founded in 1636 and located in Cambridge, Massachusetts, U.S.A. Seven Presidents of the United States have graduated from Harvard schools and colleges. It is one of the world's leading research institutions and since 1974, nineteen Harvard faculty won Nobel Prize.

The Harvard School of Public Health was founded in 1922 out of the Harvard-MIT School for Health Officers, the first graduate training program in public health in the U.S. The school fosters research aimed at improving public health for people around the world, and is involved in world-class medical research in fields such as HIV/AIDS, SARS, cancer and heart disease.


· Dr. Melvin W. First, ScD, CIH, PE
Professor of Environmental Health Engineering, Emeritus

Dr. Melvin First has more than 50 years of experience as an expert in air cleaning and filtration technology, and has specialized in academic research on living environments and improving public health. At Harvard University, he has conducted research in biotechnology fields using a special microbiological laboratory chamber capable of safely handling a wide range of viruses and bacteria with a view toward infection control. Also, techniques for microbiological evaluation in large spaces is attracting attention because of their potential application to bioterrorism defense technologies.



Overview of Plasmacluster Ion Technology
A plasma discharge generates positive ions (H+) and negative ions (O2-) from water vapor in the air. These ions have the property of clustering around micro-particles, and thus, they surround harmful substances such as airborne mold fungi, viruses and allergens. At that point, a chemical reaction occurs on the cell membrane surface, and the ions are transformed into OH radicals, a powerfully active but unstable material, which robs the harmful substance of a hydrogen atom (H). As a result, the OH radicals inactivate the harmful substances by severing the protein on the cell membrane, opening holes. The OH radicals instantly bond with the removed hydrogen (H), forming water vapor (H2O), and return to the air.

1)

The Plasmacluster Ions are the same positive and negative ions found in abundance in nature, for example, in woods and forests. They turn into OH radicals only on the surface of harmful substances to inactivate them, so they are completely harmless to the human body. The amount of ozone generated is less than 0.01 ppm, significantly below the 0.05-ppm value set as the standard for industry and for electrical equipment.

2)

Compared to passive air cleaning systems that trap airborne contaminants by using a fan to draw air through a filter, air purification systems based on Plasmacluster Ions effectively eliminate harmful substances by working directly on the air contained in the entire room.

3)

The Plasmacluster Ion generator never loses its effectiveness by becoming dirty and never needs replacing like filters. It consumes a miniscule amount of electricity (0.15 W). Annual electricity costs for continuous use are around ¥30.


1. Working mechanism to suppress airborne bacteria


2. Working mechanism to suppress airborne viruses


3.Working mechanism to suppress airborne allergens



Efficacy of Plasmacluster Ions on Various Pathogens Confirmed Through Collaborative Research
Target Substance Species Testing & Verification Organization Date of Announcement
Bacteria Serratia bacteria Dr. Melvin W. First, Professor Emeritus (Harvard School of Public Health) March 2007
Coliform bacteria ( E. coli ) Ishikawa Health Service Association, Japan September 2000
E. coli ,
Staphylococcus
( aureus ), Candida
Shanghai Municipal Center for Disease Control and Prevention, China October 2001
Bacillus subtilis a Kitasato Research Center of Environmental Sciences, Japan September 2002
CT&T (Professor Gerhard Artmann, Aachen University of Applied Sciences), Germany November 2004
MRSA
(methicillin-resistant Staphylococcus aureus)
Kitasato Research Center of Environmental Sciences, Japan September 2002
Kitasato Institute Medical Center Hospital, Japan February 2004
Pseudomonas, Enterococcus, Staphylococcus University of Lübeck, Germany February 2002
Enterococcus, Staphylococcus,
Sarcina,
Micrococcus
CT&T (Professor Gerhard Artmann, Aachen University of Applied Sciences), Germany November 2004
Allergens Mite allergen,
pollen
Graduate School of Advanced Sciences of Matter, Hiroshima University, Japan September 2003
Airborne allergens Asthma Society of Canada April 2004
Fungi Cladosporium Ishikawa Health Service Association, Japan September 2000
University of Lübeck, Germany (growth-suppressing effect) February 2002
CT&T (Professor Gerhard Artmann, Aachen University of Applied Sciences), Germany November 2004
Penicillium, Aspergillus University of Lübeck, Germany (growth-suppressing effect) February 2002
Aspergillus,
Penicillium (two species), Stachybotrys,
Alternaria,
Mucorales
CT&T (Professor Gerhard Artmann, Aachen University of Applied Sciences), Germany November 2004
Viruses H1N1 influenza virus Kitasato Research Center of Environmental Sciences, Japan September 2002
Seoul University, Korea September 2003
Shanghai Municipal Center for Disease Control and Prevention, China December 2003
Kitasato Institute Medical Center Hospital, Japan February 2004
H5N1 avian influenza virus Retroscreen Virology, Ltd., London, UK May 2005
Coxsackie virus Kitasato Research Center of Environmental Sciences, Japan September 2002
Polio virus Kitasato Research Center of Environmental Sciences, Japan September 2002
Corona virus Kitasato Institute Medical Center Hospital, Japan July 2004




The following information is true and accurate at the time of publication. Manufacture, sale, price and specifications of products may be subjected to change.


Top of Page